Merck Eprova AG and Isofol Medical Enter Exclusive Agreement for Merck Eprova's Modufolin(R) in Oncology
11/11/2009 2:15:07 PM
More...
|
PDS Biotechnology Corporation Finalizes Commercial Licensing Agreement with Merck Eprova AG
2/24/2009 11:00:18 AM
More...
|
Merck Eprova AG Highlighted For Inventing Metafolin(R) With The Frost & Sullivan Product Differentiation Innovation Award Of The Year
1/9/2007 9:57:31 AM
More...
|
EMD Chemicals, Inc. (MRK) Announces New President And CEO
11/2/2006 11:25:49 AM
More...
|
BioMarin Pharmaceutical Inc. (BMRN) Initiates Phase 3 Clinical Trial Of Phenoptin For PKU
10/19/2005 5:13:14 PM
More...
|
Merck & Co., Inc. (MRK) Innovates With Equant; Merck KGaA (MKGAF.PK) Signs New Three-Year Agreement For Customized IP VPN Solution
10/19/2005 5:12:30 PM
More...
|
Hagens Berman Release: Arizona Consumer Files First Class Action Against Vioxx Manufacturer Merck & Co., Inc. (MRK)
10/19/2005 5:12:26 PM
More...
|
Merck & Co., Inc. (MRK) Sued By Wechsler Harwood LLP
10/19/2005 5:12:26 PM
More...
|
Biomira Inc. (BIOM) And Merck KGaA (MKGAF.PK) Present Non-Small Cell Lung Cancer Data At European Society For Medical Oncology Congress (Abstract No. 3IN)
10/19/2005 5:12:02 PM
More...
|
Xenogen Corporation (XGEN) Announces Five-Year Global Licensing Agreement With Merck & Co. (MRK)
10/19/2005 5:11:49 PM
More...
|
|